EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens‐Johnson syndrome and toxic epidermal necrolysis) – Part 1: Diagnosis, initial management, and immunomodulating systemic therapy

Ruben Heuer, Maren Paulmann, Thorsten Annecke, Björn Behr, Katharina Boch, Anja M Boos, Knut Brockow, Lars E French, Jochen Gille, Verena Gundlach, Bernd Hartmann, Peter Höger und 25 weitere

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024-10 · 22 (10) · 1448-1466

DOI: 10.1111/ddg.15515 ↗

Kurz gefasst

Leitlinie in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, online erschienen am 23.09.2024. Verfasst von Ruben Heuer und 36 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, Division of Evidence Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate m…. Hauptthemen laut MEDLINE: Stevens-Johnson Syndrome. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stevens‐Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are rare, predominantly drug‐induced, acute, life‐threatening diseases of skin and mucosae. SJS and TEN are nowadays considered variants of one disease entity with varying degrees of severity called epidermal necrolysis (EN). EN is associated with high morbidity and mortality and constitutes a major disease burden for affected patients. The guideline “Diagnosis and treatment of epidermal necrolysis (Stevens‐Johnson syndrome and toxic epidermal necrolysis)” was developed under systematic consideration of existing scientific literature and in a formal consensus process according to regulations issued by the Association of Scientific Medical Societies in Germany (AWMF) to establish an evidence‐based framework to support clinical decision‐making. The interdisciplinary guideline commission consisted of representatives from various specialist societies and patient representatives. The guideline is aimed at specialists in the fields of dermatology, ophthalmology, plastic surgery, intensive care, and pediatrics in hospitals and offices, as well as other medical speciallved in the diagnosis and treatment of EN. The guideline is also aimed at patients, their relatives, insurance funds, and policymakers. This first part focuses on the diagnostic aspects, the initial management as well as the immunomodulating systemic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stevens-Johnson SyndromeHumansGermanyImmunomodulationImmunologic Factors

Stichwörter der Autor:innen

Drug reactionLyell syndromeStevens‐Johnson syndromeepidermal necrolysistoxic epidermal necrolysis

Substanzen

Immunologic Factors

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Allergology, Division of Evidence Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin,…
  • Department of Dermatology and Venereology, Dokumentationszentrum schwerer Hautreaktionen (dZh), University Medical Center Freiburg, Freiburg, Germany.
  • Department of Anesthesiology and Critical Care Medicine, Merheim Medical Center, Hospital of Witten/Herdecke University, Cologne, Germany.
  • Department of Plastic and Hand Surgery, Burn Center, Sarcoma Center, BG University Hospital Bergmannsheil Ruhr University Bochum, Bochum, Germany.
  • Department of Plastic, Reconstructive & Aesthetic Surgery, KEM Evangelische Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung Essen-Huttrop, Essen, Germany.
  • Department of Dermatology, Allergology and Venereology, University Hospital Schleswig-Holstein, Campus Lübeck, Germany.

Zitieren

APA

Heuer, R., Paulmann, M., Annecke, T., Behr, B., Boch, K., Boos, A. M., Brockow, K., French, L. E., Gille, J., Gundlach, V., Hartmann, B., Höger, P., Hofmann, S. C., Klein, T., Lehnhardt, M., Liß, Y., Maier, P., Mandel, P., Marathovouniotis, N., …, & Nast, A. (2024). S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens‐Johnson syndrome and toxic epidermal necrolysis) – Part 1: Diagnosis, initial management, and immunomodulating systemic therapy. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(10), 1448-1466. https://doi.org/10.1111/ddg.15515

Vancouver

Heuer R, Paulmann M, Annecke T, Behr B, Boch K, Boos AM, et al. S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens‐Johnson syndrome and toxic epidermal necrolysis) – Part 1: Diagnosis, initial management, and immunomodulating systemic therapy. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024;22(10):1448-1466. doi:10.1111/ddg.15515

BibTeX
@article{Heuer2024,
  author = {Heuer, Ruben and Paulmann, Maren and Annecke, Thorsten and Behr, Björn and Boch, Katharina and Boos, Anja M and Brockow, Knut and French, Lars E and Gille, Jochen and Gundlach, Verena and Hartmann, Bernd and Höger, Peter and Hofmann, Silke C and Klein, Tobias and Lehnhardt, Marcus and Liß, Yvonne and Maier, Philip and Mandel, Philipp and Marathovouniotis, Nicos and Marlok, Finnja and Mittelviefhaus, Hans and Pleyer, Uwe and Pradeau, Marie and Rall, Katharina and Rieg, Siegbert and Rittner, Heike and Sander, Frank and Schnitzler, Stefan and Schut, Christina and Stolle, Annette and Vorobyev, Artem and Wedi, Bettina and Weiss, Johannes and Zepp, Maximilian and Ziemer, Mirjana and Mockenhaupt, Maja and Nast, Alexander},
  title = {S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens‐Johnson syndrome and toxic epidermal necrolysis) – Part 1: Diagnosis, initial management, and immunomodulating systemic therapy},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2024},
  volume = {22},
  number = {10},
  pages = {1448--1466},
  doi = {10.1111/ddg.15515}
}
Kostenlos starten →